Taisho Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Taisho Pharmaceutical Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11023
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Taisho Pharmaceutical Co Ltd (Taisho), a subsidiary of Taisho Pharmaceutical Holdings Co Ltd is a pharmaceutical company that develops, manufactures and markets a range of prescription pharmaceutical and self-medication drugs. The company offers products such as lipovitan D, riup, clarith, zosyn and palux, pabron, taisho kampo ichoyaku, others. It business segments include self-medication, prescription pharmaceutical, and overseas development. Taisho also sells macrolide antibiotic agent clarith. The company markets its products through distributors in Malaysia, the Philippines, Indonesia, Thailand, Hong Kong, Taiwan, Australia, the US, the UK, Vietnam and China. Taisho is headquartered in Tokyo, Japan.

Taisho Pharmaceutical Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Polyphor Enters into Research Agreement with Taisho Pharma 10
Taisho Pharma Enters into Distribution Agreement with Biofermin Pharma 11
Licensing Agreements 12
Taisho Pharma Enters into Licensing Agreement with Bayer Yakuhin 12
Asset Transactions 13
Eisai to Acquire Rights of Kolbet from Toyoma Chemical and Taisho Pharma 13
Acquisition 14
Taisho Pharma to Acquire Additional 7.06% Stake in Duoc Hau Giang Pharma 14
Taisho Pharma to Acquire Dr. Program from Kyorin Pharma 15
Taisho Pharma Acquires 24.5% stake in Duoc Hau Giang Pharma 16
Taisho Pharmaceutical Co Ltd – Key Competitors 17
Taisho Pharmaceutical Co Ltd – Key Employees 18
Taisho Pharmaceutical Co Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Taisho Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Polyphor Enters into Research Agreement with Taisho Pharma 10
Taisho Pharma Enters into Distribution Agreement with Biofermin Pharma 11
Taisho Pharma Enters into Licensing Agreement with Bayer Yakuhin 12
Eisai to Acquire Rights of Kolbet from Toyoma Chemical and Taisho Pharma 13
Taisho Pharma to Acquire Additional 7.06% Stake in Duoc Hau Giang Pharma 14
Taisho Pharma to Acquire Dr. Program from Kyorin Pharma 15
Taisho Pharma Acquires 24.5% stake in Duoc Hau Giang Pharma 16
Taisho Pharmaceutical Co Ltd, Key Competitors 17
Taisho Pharmaceutical Co Ltd, Key Employees 18
Taisho Pharmaceutical Co Ltd, Other Locations 19

List of Figures
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Taisho Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BlackRock Inc:企業の戦略・SWOT・財務情報
    BlackRock Inc - Strategy, SWOT and Corporate Finance Report Summary BlackRock Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Ambry Genetics Corp-製薬・医療分野:企業M&A・提携分析
    Summary Ambry Genetics Corp (Ambry Genetics) is a biotechnology company that offers genetic testing services. The company offers clinical diagnostics services, which include tests, forms, billing, managed care, order kits, reporting, licenses, family studies program, variant classification and secur …
  • Covaris Inc-医療機器分野:企業M&A・提携分析
    Summary Covaris Inc (Covaris) is a technology company that offers pre-analytical tools and devices. The company’s products comprise instruments, kits and reagents and consumables. It offers kits and reagents which include truXTRAC FFPE DNA and RNA Kits; truXTRAC automation, FFPE sample collection, t …
  • Covestro AG (1COV):企業の財務・戦略的SWOT分析
    Covestro AG (1COV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Petron Corp (PCOR):石油・ガス:M&Aディール及び事業提携情報
    Summary Petron Corp (Petron), a subsidiary of San Miguel Corporation, is a downstream energy company. It refines and markets an array of petroleum products including gasoline, liquefied petroleum gas, diesel, jet fuel, kerosene, industrial fuel oil, solvents, asphalts; and petrochemical feedstocks s …
  • SBI Biotech Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary SBI Biotech Co Ltd (SBI), a subsidiary of SBI Holdings Inc, is a developer of molecule targeting drugs and immune modulation drugs. The company develops DNA nucleotide drugs targeting TLR and antibody drugs targeting dendritic cells. Its pipeline products include ILT7, SBI-9674, SBI-3150, GN …
  • Eagle Cement Corporation (EAGLE):企業の財務・戦略的SWOT分析
    Eagle Cement Corporation (EAGLE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • The Interpublic Group of Companies, Inc.:企業の戦略・SWOT・財務分析
    The Interpublic Group of Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Interpublic Group of Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Ferno-Washington Inc:企業の戦略的SWOT分析
    Ferno-Washington Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Fugro NV (FUR):企業の財務・戦略的SWOT分析
    Fugro NV (FUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Microvision Inc (MVIS):企業の財務・戦略的SWOT分析
    Summary Microvision Inc (Microvision) is a technology company that provides scanning technology solutions. The company offers technology solutions including PicoP scanning technology, an ultra-miniature laser projection and imaging solutions based on the laser beam scanning methodology. It also prov …
  • MBNA Ltd:企業の戦略・SWOT・財務情報
    MBNA Ltd - Strategy, SWOT and Corporate Finance Report Summary MBNA Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • SMCP S.A.S (SMCP):企業の財務・戦略的SWOT分析
    SMCP S.A.S (SMCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Massachusetts General Hospital-医療機器分野:企業M&A・提携分析
    Summary Massachusetts General Hospital (MGH) is a healthcare service provider which offers diagnostic and therapeutic care services. The hospital provides services such as allergy and immunology; ALS multidisciplinary clinic, anesthesia, critical care and pain medicine; back bay healthcare center, b …
  • Medimetriks Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Medimetriks Pharmaceuticals Inc (MPI) is a specialty pharmaceutical company that offers skincare products. The company provides personal care products such as cleansers, nutritional supplements, cosmetic creams, topical suspension, ointment, topical solution, and moisturizer. It offers produ …
  • Franz Haniel & Cie. GmbH:企業の戦略・SWOT・財務分析
    Franz Haniel & Cie. GmbH - Strategy, SWOT and Corporate Finance Report Summary Franz Haniel & Cie. GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Delegat’s Group Limited:戦略・SWOT・企業財務分析
    Delegat's Group Limited - Strategy, SWOT and Corporate Finance Report Summary Delegat's Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Kvaerner ASA (KVAER)-石油・ガス分野:企業M&A・提携分析
    Summary Kvaerner ASA (Kvaerner) is a provider of engineering, procurement and construction (EPC) services. It holds expertise in providing EPC services to steel substructures, topsides, concrete structures and onshore facilities. Its service portfolio includes project management, front-end engineeri …
  • Worthington Industries Inc:戦略・SWOT・企業財務分析
    Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Harting AG & Co KG:企業の戦略的SWOT分析
    Harting AG & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆